{"nct_id":"NCT06256484","title":"A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","status":"TERMINATED","status_verified_date":"2025-04","start_date":"2024-09-06","start_date_type":"ACTUAL","primary_completion_date":"2025-03-03","primary_completion_date_type":"ACTUAL","completion_date":"2025-03-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ATRA"]}